In case you missed the original announcement,  the AMPLIFY 2012 Convention will be host to a special symposium on RiboCeine™ featuring both Herbert Nagasawa, Ph.D. and Scott Nagasawa, Pharm.D.  The symposium is scheduled at 9:00 A.M. on Thursday, April 12.

Dr. Herbert Nagasawa will share his story about the development of RiboCeine, from his initial hypothesis through 25 years of research and development, up to the key studies that demonstrated the effectiveness of this breakthrough compound.  Attendees will learn firsthand of the technical and scientific details that make Cellgevity™, MaxOne™, and MaxATP™ possible.

The presentation will last for 30 minutes and be followed by a Q & A session.  Breakfast will be included for all attendees.

Due to the technical nature of this symposium, attendance will be exclusive to licensed healthcare professionals and Ph.Ds.  Any Associate wishing to receive an official invitation will need to fax or email a copy of their current license or degree to the Max office. Please include your Associate ID number, a current telephone number, and current email address.  You will then be contacted with instructions on how to register.

When: 9:00 A.M. on Thursday, April 12, 2012
Who: Medical Professionals – send Associate ID, current telephone and email address and a copy of healthcare license or Ph.D degree to:

Email:  Send a scanned copy to [email protected].
Fax:  Send to (801) 255-5238, attention Amplify Convention.

Reminder: Register for the Exclusive RiboCeine Symposium is a post from: